Background: For effective development of policy for faculty advances, it is necessary to know students' views. This study describes the perceptions of clinical students about teaching skills of faculty in the dental schools in Nigeria.
Methods: A validated, self-administered questionnaire adapted from Clinical Education Instructional Quality was used to survey 109 dental students from the three dental schools in Nigeria. Score of > or = 45 and > or = 39 was considered good perceptions for "interaction with clinical instructors" and "involvement in specific learning" respectively. Computed perception scores were compared by year of training.
Results: Participants comprised 64 males and 45 females; aged 21.0 to 35.0 years (mean age = 24.2 +/- 2.5 years). Majority (89.0%) of the students had good perception of their interaction with clinical instructors while 89.9% had good perception about their involvement in learning activities. More students in year three than two had positive perception about their interaction with clinical instructors and involvement in activities.
Conclusion: Overall, dental students in Nigeria had good perception of their interaction with their clinical instructors and involvement in various learning activities but they desired more opportunity to get involve especially in the aspects of dental procedures, patients' vital signs and interpretation of laboratory tests.
Download full-text PDF |
Source |
---|
Alzheimers Dement
December 2024
Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, Beijing, China.
Background: The DL-3-n-butylphthalide (NBP), a multi-target neuroprotective drug, improving cognitive impairment in patient with vascular cognitive impairment has been confirmed. The efficacy of NBP in patients with cognitive impairment due to Alzheimer's disease (AD) remains unknown. This study aimed to evaluate the efficacy and safety of NBP in patients with mild cognitive impairment (MCI) due to AD though a clinical randomized controlled trail.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Henan Academy of Innovations in Medical Science, Zhengzhou, Henan, China.
Background: Glucagon-like peptide 1 (GLP-1) is a peptide hormone that plays several physiological roles in treating diabetes and in protecting the brain. Recent clinical trials testing 4 different GLP-1 class drugs in phase 2 trials showed a clear correlation between neuroprotection and the ability to cross the BBB. Exenatide and Lixisenatide both showed excellent protective effects in patients Parkinson's disease (PD) and both drugs can readily cross the BBB.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
NYU Grossman School of Medicine, New York, NY, USA; NYU, New York City, NY, USA.
Background: Astrocytes, a major glial cell in the central nervous system (CNS), can become reactive in response to inflammation or injury, and release toxic factors that kill specific subtypes of neurons. Over the past several decades, many groups report that reactive astrocytes are present in the brains of patients with Alzheimer's disease, as well as several other neurodegenerative diseases. In addition, reactive astrocyte sub-types most associated with these diseases are now reported to be present during CNS cancers of several types.
View Article and Find Full Text PDFBackground: Alzheimer's disease (AD) is the most prevalent cause of dementia accounting for an estimated 60% to 80% of cases. Despite advances in the research field, developing truly effective therapies for AD symptoms remains a major challenge. Sweet almond contain nutrients that have the potential of combating age-related brain dysfunction, by improving learning, memory and neurocognitive performance.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India.
Background: The present study recapitulates the potency of the novel synthesized piperazine-benzoquinone derivative as a lead molecule selectively targeting AChE along with the antioxidative potential for the management of cognitive decline in Alzheimer's disease.
Method: Novel piperazine-benzoquinone derivative was synthesized implementing appropriate synthetic procedures and was characterized by various spectral and elemental techniques. The purity of this synthetic analogue was ascertained by TLC, melting point determination and elemental analyses.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!